Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Synopsys stock
Learn how to easily invest in Synopsys stock.
Synopsys Inc is a software-infrastructure business based in the US. Synopsys shares (SNPS) are listed on the NASDAQ and all prices are listed in US Dollars. Synopsys employs 16,361 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Synopsys
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SNPS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- SNPS shares summary
- Compare share dealing platforms
- Is SNPS stock a buy or sell?
- Stock performance over time
- Is SNPS suitable for ethical investing?
- Are SNPS shares over-valued?
- Synopsys's financials
- How volatile are SNPS shares?
- Does Synopsys pay a dividend?
- Have SNPS shares ever split?
- Other common questions
Synopsys stock price (NASDAQ: SNPS)Use our graph to track the performance of SNPS stocks over time.
Synopsys shares at a glance
|Latest market close||$301.23|
|52-week range||$255.02 - $377.60|
|50-day moving average||$298.06|
|200-day moving average||$317.28|
|Wall St. target price||$382.49|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$6.47|
Buy Synopsys shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Synopsys stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Synopsys price performance over time
|1 week (2022-06-28)||-0.80%|
|1 month (2022-06-02)||-8.94%|
|3 months (2022-04-05)||-8.08%|
|6 months (2022-01-05)||-11.34%|
|1 year (2021-07-02)||7.91%|
|2 years (2020-07-02)||52.46%|
|3 years (2019-07-05)||122.47%|
|5 years (2017-07-05)||314.12%|
Is Synopsys stock undervalued or overvalued?
Valuing Synopsys stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Synopsys's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Synopsys's P/E ratio
Synopsys's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 47x. In other words, Synopsys shares trade at around 47x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Synopsys's PEG ratio
Synopsys's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0961. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Synopsys's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Synopsys's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.3 billion.
The EBITDA is a measure of a Synopsys's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.8 billion|
|Operating margin TTM||24.13%|
|Gross profit TTM||$3.4 billion|
|Return on assets TTM||8.18%|
|Return on equity TTM||18.81%|
|Market capitalisation||$46.1 billion|
TTM: trailing 12 months
Synopsys's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Synopsys.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Synopsys's total ESG risk score
Total ESG risk: 21.54
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Synopsys's overall score of 21.54 (as at 12/31/2018) is excellent – landing it in it in the 14th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Synopsys is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Synopsys's environmental score
Environmental score: 9.6/100
Synopsys's environmental score of 9.6 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Synopsys is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Synopsys's social score
Social score: 14.57/100
Synopsys's social score of 14.57 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Synopsys is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Synopsys's governance score
Governance score: 9.87/100
Synopsys's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that Synopsys is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Environmental, social, and governance (ESG) summary
|Total ESG score||21.54|
|Total ESG percentile||14.2|
|Environmental score percentile||9|
|Social score percentile||9|
|Governance score percentile||9|
Synopsys share dividends
We're not expecting Synopsys to pay a dividend over the next 12 months.
Have Synopsys's shares ever split?
Synopsys's shares were split on a 2:1 basis on 23 September 2003. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Synopsys shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Synopsys shares which in turn could have impacted Synopsys's share price.
Synopsys share price volatility
Over the last 12 months, Synopsys's shares have ranged in value from as little as $255.02 up to $377.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Synopsys's is 1.1987. This would suggest that Synopsys's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It also provides intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip (SoC) infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating-point components, and Arm AMBA interconnect fabric and peripherals. In addition, the company offers logic libraries and embedded memories; configurable processor cores and application-specific instruction-set processor tools for embedded applications; IP subsystems for audio, sensor, and data fusion functionality; and security IP solutions. Further, it provides Platform Architect solutions for SoC architecture analysis and optimization; virtual prototyping solutions; and HAPS FPGA-based prototyping systems, as well as a series of tools used in the design of optical systems and photonic devices. Additionally, the company offers security testing, managed services, programs and professional services, and training that enable its customers to detect and remediate security vulnerabilities, and defects in the software development lifecycle, as well as manufacturing solutions.
Synopsys in the news
Ready to Get Rich With Stocks? You Can't Go Wrong With These 3 Investments
Chip Design Firms Upgraded As Chipmakers Downgraded
Synopsys and Arm Strengthen Partnership to Advance Next-Gen Mobile SoCs for Arm's Total Compute Solutions
Frequently asked questionsWhat percentage of Synopsys is owned by insiders or institutions?
Currently 0.579% of Synopsys shares are held by insiders and 92.131% by institutions. How many people work for Synopsys?
Latest data suggests 16,361 work at Synopsys. When does the fiscal year end for Synopsys?
Synopsys's fiscal year ends in October. Where is Synopsys based?
Synopsys's address is: 690 East Middlefield Road, Mountain View, CA, United States, 94043 What is Synopsys's ISIN number?
Synopsys's international securities identification number is: US8716071076 What is Synopsys's CUSIP number?
Synopsys's Committee on Uniform Securities Identification Procedures number is: 871607107
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert